Caredx demonstrates innovation leadership at 2023 transplant congress

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced a leading presence at the 2023 american transplant congress (atc) with 65 scientific presentations. caredx will also be hosting a satellite symposium1 and sponsoring the women's networking event. the atc meeting takes place june 3.
CDNA Ratings Summary
CDNA Quant Ranking